Genedata Announces Collaboration with AstraZeneca on the Analysis of Compound Combination Experiments

Basel, Switzerland - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its successful collaboration with AstraZeneca on data analysis for compound combination experiments. Drug combination studies, which are increasingly used in pre-clinical research, produce large volumes of data with upwards to 200 combinations per experiment. Genedata [...]

ImmunoChemistry Technologies Changes Ownership

Minneapolis, MN -- ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans. The privately held company is [...]

BioNano Genomics Announces the Adoption of Irys System by the Garvan Institute of Medical Research

SAN DIEGO and SYDNEY -- BioNano Genomics announced today the Garvan Institute of Medical Research has elected to incorporate the Irys technology into their disease research programs, with particular emphasis on improving understanding of prostate cancer. With their purchase of an Irys System, Garvan becomes the first Early Access user of the technology in Australia. [...]

Driving European Drug Discovery with Mosaic

LONDON, UK -- Leading sample management software provider, Titian Software, has announced that its Mosaic software is to play a central role in compound library screening for a major new European drug discovery initiative, the European Lead Factory (ELF). Following a successful bid to the Innovative Medicines Initiative (IMI), over 8.7m euros has been invested [...]

New System from Baker Ruskinn Accelerates Oxygen Regulation in Culture Media

SANFORD, Maine -- HypoxyCOOLTM, the new media conditioning system from Baker Ruskinn, accelerates the reduction of oxygen concentration in tissue/cell culture media to user-defined values by as much as two days. The system is the first commercialized solution for precisely controlling oxygen levels in liquid media used in stem cell expansion or any tissue culture [...]

Enhanced General Purpose Centrifuge Product Line Increases Capacity and Flexibility

WALTHAM, Mass. -- New enhanced general purpose centrifuge product line offers clinical and life science researchers the ability to spin more samples in a single run while maximizing critical lab space. The Thermo Scientific general purpose centrifuges feature increased capacity and flexibility with rotor innovations including the new Thermo Scientific TX-1000 rotor, which is the [...]

DNAnexus Collaboration Yields New Genetic Variant Data Set for 1000 Genomes Project

MOUNTAIN VIEW, Calif. -- DNAnexus, a pioneer in cloud-based solutions for large-scale DNA data management and analysis, today announced a collaboration with Stanford University that has resulted in a new 1000 Genomes Project data set of genetic variation. Through this collaboration, scientists have analyzed and identified genetic variants in more than 80 terabytes (TB) of [...]

Byron Hewett appointed as new SomaLogic CEO

The Board of Directors of SomaLogic Inc. (a privately held biotechnology company) announced today that Byron Hewett has been appointed as Chief Executive Officer (CEO), effective Dec 2, 2013. SomaLogic was founded in 2000 by its original CEO, Larry Gold, who will continue as Chairman of the Board. Dr. Gold will also continue to work [...]

Molecular Devices Announces Next-Generation SpectraMax MiniMax 300 Imaging Cytometer

Sunnyvale, CA – Molecular Devices®, the market leader in microplate reader technology for over 25 years, has announced today the next-generation SpectraMax® MiniMax™ 300 Imaging Cytometer. This MiniMax 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax® i3 Multi-Mode Microplate Reader. Brightfield and fluorescence based green and [...]

ATCC and Evercyte form a partnership to develop and distribute immortalized human cells and cell lines

Manassas, VA – ATCC, the premier global biological materials resource and standards organization, and Evercyte GmbH, a proven developer of immortalized human cells, have entered into a strategic partnership to develop and distribute immortalized cell lines that retain key performance characteristics of primary cells. Immortalized primary cell lines enable scientists to have a sufficient supply [...]

Access IBO on Knowledge Center